Products / Infectology

Tri-Zevuvir

Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg

Dolutegravir + Emtricitabine + Tenofovir Alafenamide are indicated in combination with other antiretroviral drugs for the treatment of adults infected with the human immunodeficiency virus type 1 (HIV-1).

Therapeutic Action

Antiretroviral

Presentations

30 coated tablets

This pharmaceutical product is gluten free. Suitable for celiacs.
Tri-Zevuvir Dolutegravir 50 mg + Emtricitabine 200 mg + Tenofovir Alafenamide 25 mg de Laboratorios Richmond
Download Prospect

Legal Notice

Products which continue to have a valid patent protection at present are manufactured in line with the current laws of the Argentine Republic. Please, take into account that our products will only be shipped to countries where the substance and its use are not protected by patents.

Laboratorios Richmond S.A.C.I.F. Argentina © All rights reserved Terms of use